Trials / Completed
CompletedNCT03697967
Supine vs Prone Position During Delayed Cord Clamping
Supine vs Prone Position During Delayed Cord Clamping in Term Infants A Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Maisonneuve-Rosemont Hospital · Academic / Other
- Sex
- All
- Age
- 1 Minute – 2 Minutes
- Healthy volunteers
- Accepted
Summary
This study is conducted to evaluate if the prone position of the newborn on the chest of his mother at birth before delayed cord clamping leads to better hematocrit and hemoglobin at 24-48 hours of life compared to supine position.
Detailed description
At 30 hours of life, laboratory personnel drew a capillary sample from the infant's heel for hemoglobin, hematocrit, and total serum bilirubin at the same time as the newborn metabolic screening sample. There is no added heelstick to routine care, as current standard in our institution requires the bilirubin to be drawn at 30 hours of life. During universal screening for congenital cardiac defects (30 hours of life), a value of cerebral saturation (CrSO2) is measured using NIRS with INVOS (In Vivo Optical Spectroscopy, INVOS System, Covidien, Dublin, Ireland, Somanetics). Sensors are placed over the forehead and the newborn is in supine position.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | supine or prone position | Before delivery, a sealed enveloppe is opened by the physician or nurse present at delivery. Immediately at birth the team in charge of delivery place the newborn in skin to skin contact on the mother's chest where he is dried. Umbilical cord clamping is delayed in both intervention arms to 1 minute after birth. The newborn is placed in the prone or in the supine position depending on allocation. The nurse in charge of the newborn uses a stopwatch to check the time at which clamping was accomplished. All subsequent nursery care are conducted according to hospital protocol. |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2021-11-01
- Completion
- 2021-11-01
- First posted
- 2018-10-05
- Last updated
- 2022-04-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03697967. Inclusion in this directory is not an endorsement.